Notice of Intent to Award a Blanket Purchase Agreement to a Single Firm for Sterilely Compounded Pharmaceuticals via 503B Compounding Pharmacies for Gallup Indian Medical Center
Closed Special Notice Posted
- Solicitation number
- IRC-GSUT2-20260002
- Agency
-
Indian Health Service
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Gallup, New Mexico 87301, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Indian Health Service, under the Department of Health and Human Services, has published a Special Notice announcing its intent to award a single Blanket Purchase Agreement (BPA) to Fagron Compounding Services LLC for the supply of sterilely compounded pharmaceuticals to Gallup Indian Medical Center in Gallup, New Mexico. The notice, posted on January 13, 2026, indicates that the government intends to establish this single-source BPA for an FDA-designated 503B compounding facility to provide medications on an as-needed basis. The procurement falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,300 employees and is classified under PSC code 6505 (Drugs and Biologicals). Market research conducted by the government indicates that the identified vendor is the only source capable of meeting the specified requirements.
The BPA will cover a base period from February 1, 2026, through January 31, 2027, with four optional renewal periods extending through January 31, 2031, and will include sterilely compounded pharmaceuticals such as Phenylephrine, Succinylcholine, LET syringes, Oxytocin, and Epinephrine in various strengths and volumes. All products must be manufactured in an FDA-approved facility with a beyond-use date of at least 30 days from manufacture. Prospective contractors who believe they are capable of fulfilling the government's requirements are encouraged to submit their capability statements, price lists, and catalogs via email to the point of contact no later than January 28, 2026, at 10:00 AM. As a single-source award under FAR 12.201-1(e)(3)(i)(B), this BPA is intended for purchases at or below the simplified acquisition threshold. The government has indicated that no further awards will be made unless Gallup Indian Medical Center's needs change.
Notice text
The Navajo Area Indian Health Service, Gallup Service Unit in Gallup, NM, intends to award a single Blanket Purchase Agreement (BPA) with Fagron Compounding Services LLC (UEI: F7QNV46N18Q4) doing business as Fagron Sterile Services for sterilely compounded pharmaceuticals from an FDA-designated 503B facility on an as-needed basis. Items include Phenylephrine 100mcg.ml, Succinylcholine 20mg/10ml, LET 5ml syringe, Oxytoxin 30 units in 500ml (sterile to sterile and API), Epinephrine 8mg per 250ml bag (or other strength/volumes of the same medications in IV bags as available and required on an as-needed basis). Products must be sterilely compounded in an FDA approved facility with a beyond use date of at least 30 days from manufacture.
The anticipated period of performance is:
Base Period: 2/1/2026-1/31/2027
Option Period One: 2/1/2027-1/31/2028
Option Period Two: 2/1/2028-1/31/2029
Option Period Three: 2/1/2029-1/31/2030
Option Period Four: 2/1/2030-1/31/2031
The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 325412- Pharmaceutical Preparation Manufacturing with a small business size standard of 1,300 employees.
No further awards will be made unless the need for Gallup Indian Medical Center changes. The prospective BPA identified in this notice is sufficient at this time. The identified vendor has the capability to provide sterilely compounded pharmaceuticals in a 503B facility and market research indicates the vendor is the only source. In accordance with Part 12.201-1(e)(3)(i)(B), BPAs may be established with a single firm from which numerous individual purchases at or below the simplified acquisition threshold will likely be made in a given period.
Any other sources that believe they are capable of fulfilling the government requirements as described are encouraged to submit their capability statement, price lists, and catalogs to the point of contact below via email only and no later than 1/28/2026 at 10:00AM (MST). In the event additional BPAs are deemed to be in the best interest of the government, capable vendors may be contacted and be requested to establish a BPA with the Government.
This notice of intent is not a request for quotations and a solicitation will not be issued.
Primary Point of Contact:
Rodney Brown, Contract Specialist
Email: Rodney.Brown@ihs.gov
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Award / Sole Source - Pyxis Automated Dispensing Systems for controlled drugs & medication services - Tsaile Health Center | Indian Health Service | No set-aside | |
| Notice of Intent to award sole source - Compact Robotic Prescription Dispensing System - Tsaile Health Center | Indian Health Service | No set-aside | |
| WRSU - Simplifi Med Trays | Indian Health Service | Indian Small Business Economic Enterprise | |
| Fisher Medical and Lab supplies | Indian Health Service | Total Small Business | |
| Nonpersonal Services - Hospitalist - Phoenix Area IHS - ISBEE Set-aside | Indian Health Service | Buy Indian |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity